Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Insider Trading > Leap Therapeutics Inc. > Profile

Leap Therapeutics Inc. (LPTX)

Sector: Pharmaceutical Preparations

Hedge Fund Holdings

Filing Period:

Last updated on November 20, 2018, 5:24 pm based on SEC 13F filings Last update: November 20, 2018, 5:24 pm

No.	Hedge Fund	Shares	Value (x$1000)	Activity	% Port
1.	DAFNA Capital Management Nathan Fischel	140,643	$1,096	-8%	0.45%
2.	683 Capital Partners Ari Zweiman	150,000	$1,169		0.07%
3.	Point72 Asset Management Steve Cohen	0	$0		0%
4.	Renaissance Technologies Jim Simons	138,868	$1,082	+24%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Onsi	$6.09	1,057,769	Large Shareholder, Officer	3,573,376	2017-11-14	Filing
Healthcare	$6.09	1,057,769	Large Shareholder	3,573,376	2017-11-14	Filing
Mirabelli	$6.09	1,057,769	Large Shareholder, Officer, Director	3,573,376	2017-11-14	Filing
Lawlor	$6.09	1,057,769	Large Shareholder, Officer	3,573,376	2017-11-14	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value (x$1000)	% Port
1.	Sphera Funds Management Ltd.	332,525	$2,590	0.29%
2.	Drw Securities, Llc	48,500	$378	0.02%
3.	Morgan Stanley	114	$1	0%
4.	Deutsche Bank Ag\	85,338	$664	0%
5.	Royal Bank Of Canada	13	$0	0%